Table 3.
Economic outcomes—post propensity score matching (PSM) and generalized estimating equation model (GEE) adjustment.
| Predicted Mean Annualized Cost | aTIV N = 234,313 |
TIV-HD N = 234,313 |
Incremental Mean | ||
|---|---|---|---|---|---|
| Mean | 95% CIs | Mean | 95% CIs | ||
| All-cause total | $9999 | $9925–$10,069 | $10,022 | $9963–$10,088 | $23.24 |
| Influenza-related total | $28.21 | $24.60–$32.39 | $31.77 | $27.73–$36.26 | $3.56 |
| Influenza-related hospitalizations | $27.59 | $23.00–$32.85 | $26.29 | $22.41–$30.81 | −$1.30 |
| Influenza-related ER | $3.97 | $3.52–$4.43 | $4.49 | $3.99–$4.97 | $0.52 |
| Influenza-related office visit + oseltamivir | $1.10 | $1.04–$1.17 | $1.36 | $1.29–$1.45 | $0.26 |
Influenza-related total = sum of (Influenza-related hospitalizations, Influenza-related ER, Influenza-related office visit + oseltamivir).